Difference between revisions of "Part:BBa K4676002:Design"
| Line 1: | Line 1: | ||
The sequence for the fusion protein was published as supplementary information by Lénon et al. in their paper "Improved production of Humira antibody in the genetically engineered Escherichia coli SHuffle, by co-expression of human PDI-GPx7 fusions." (1) | The sequence for the fusion protein was published as supplementary information by Lénon et al. in their paper "Improved production of Humira antibody in the genetically engineered Escherichia coli SHuffle, by co-expression of human PDI-GPx7 fusions." (1) | ||
| + | |||
| + | 1. Lenon, M., Ke, N., Szady, C., Sakhtah, H., Ren, G., Manta, B., Causey, B., & Berkmen, M. (2020, September 30). Improved production of Humira antibody in the genetically engineered escherichia coli shuffle, by co-expression of human PDI-GPX7 fusions - Applied Microbiology and Biotechnology. SpringerLink. https://link.springer.com/article/10.1007/s00253-020-10920-5 | ||
Revision as of 00:42, 12 October 2023
The sequence for the fusion protein was published as supplementary information by Lénon et al. in their paper "Improved production of Humira antibody in the genetically engineered Escherichia coli SHuffle, by co-expression of human PDI-GPx7 fusions." (1)
1. Lenon, M., Ke, N., Szady, C., Sakhtah, H., Ren, G., Manta, B., Causey, B., & Berkmen, M. (2020, September 30). Improved production of Humira antibody in the genetically engineered escherichia coli shuffle, by co-expression of human PDI-GPX7 fusions - Applied Microbiology and Biotechnology. SpringerLink. https://link.springer.com/article/10.1007/s00253-020-10920-5